Home  /  News Of Farmacy  /  Núm: 1 Par: PP (2015)  /  Article
ARTICLE
TITLE

The assessment of the method for quantitative determination of prednisolone in the oThe assessment of the method for quantitative determination of prednisointment by the reaction with phenylhydrazine

SUMMARY

Adaptation and validation of the analytical method of photocolorimetric determination of prednisolone using the reaction with phenylhydrazine by the standard method have been carried out in the scientific research laboratory according to standard procedures as described in the State Pharmacopoeia of Ukraine. The main validation characteristics have been identified using the model solution with standard substance. It has been found that the criteria of linearity and precision are observed in the range of concentration of 80-120% (0,08-0,12 mg/ml in the test solution or 0,4-0,6% of prednisolone in the ointment), and they are statistically and practically insignificant (a = Sa×1,86=4,7, ?as% = 3,20= 2,86, d=1,0240=0,92). The correct results obtained have allowed to test the method for determining prednisolone in the model extraction from "0.5% Prednisolone" ointment in the range of 80-120% of the nominal concentration. The study of robustness of the method has allowed to determine that it is necessary to follow a strict temperature range during the reaction to produce correct results (60°C ±1°). The amount of phenylhydrazine in the reagent may vary between 0,4-1,0 g/l. Criteria of linearity, precision and convergence for the model extraction of the ointment are also observed within the whole range of the determination and are statistically and practically insignificant (a = Sa×1,86=4,4, ?as,% =3,20=2,71, d=1,0240=1,00). The method is acceptable for use in laboratories of the drug quality control and could be applied for determination of prednisolone in "0.5% Prednisolone" ointment with the hydrophobic base within the range of concentration of 0.4-0.6%.

 Articles related

K. L. Ratushna    

Qualitative data are one of the essential elements of the clinical trial quality; they contribute to the evidence-based substantiation of efficacy and safety of a drug making a great impact on success of its approval by regulatory bodies. The paper outli... see more


Teja Voruganti,Mary Ann O'Brien,Sharon E. Straus,John R. McLaughlin,Eva Grunfeld    

Background Health risk assessment tools compute an individual’s risk of developing a disease. Routine use of such tools by primary care physicians (PCPs) is potentially useful in chronic disease prevention. We sought physicians’ awareness and perceptions... see more


Robert Bernstein,Gary Hollingworth,Gary Viner,Paul Miller    

Background: Data entry into electronic medical records remains a barrier to their use in primary care. One of the difficulties in data recording has been the use of terminologies unsuited to clinical data entry by physicians. Canada has chosen ICD-10 as ... see more


Najmiatul Fitria,Lailaturrahmi Lailaturrahmi,Yelly Oktavia Sari,Fahira Tri Anata,Khairatul Husnia 10.25077/jsfk.10.1.28-34.2023    

Adherence is a major problem in hypertension treatment. Patients' adherence can be evaluated through pill count by counting the remaining amount of the patient's medication at the beginning and the end, using a pillbox as a tool to improve patient medica... see more


Deepashini Harithasan    

Objective: Standardized self-report questionnaires are considered as the most widely used and low cost approach to measure spoken language development. We provide an overview of the questionnaires available for assessing the spoken language development a... see more